Semmax Financial Advisors Inc. - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 311 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.

Quarter-by-quarter ownership
Semmax Financial Advisors Inc. ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,842
+127966.7%
82
-2.4%
0.00%
+100.0%
Q4 2022$3
-99.9%
840.0%0.00%
-50.0%
Q3 2022$4,000
-96.3%
84
-96.4%
0.00%
-95.5%
Q2 2022$107,000
+12.6%
2,327
-9.6%
0.04%
+18.9%
Q1 2022$95,000
+13.1%
2,574
-7.2%
0.04%
+19.4%
Q4 2021$84,000
-27.0%
2,775
-19.1%
0.03%
-22.5%
Q3 2021$115,000
-23.8%
3,431
-9.4%
0.04%
-16.7%
Q2 2021$151,000
-16.6%
3,786
-6.0%
0.05%
-25.0%
Q1 2021$181,000
+8950.0%
4,028
+10228.2%
0.06%
+6300.0%
Q4 2020$2,0000.0%390.0%0.00%0.0%
Q3 2020$2,0000.0%390.0%0.00%0.0%
Q2 2020$2,0000.0%390.0%0.00%0.0%
Q1 2020$2,0000.0%390.0%0.00%0.0%
Q4 2019$2,0000.0%390.0%0.00%0.0%
Q3 2019$2,000
-33.3%
390.0%0.00%
-50.0%
Q2 2019$3,0000.0%390.0%0.00%0.0%
Q1 2019$3,000
+50.0%
390.0%0.00%0.0%
Q4 2018$2,000390.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,541,046$126,5576.89%
M28 Capital Management LP 126,300$4,513,9625.10%
Bellevue Group AG 9,511,900$339,955,3064.93%
Deep Track Capital, LP 2,834,069$101,289,6264.16%
BVF INC/IL 2,560,761$91,521,5983.35%
Sicart Associates LLC 210,698$7,530,3472.93%
Privium Fund Management B.V. 182,773$6,532,3072.19%
Camber Capital Management LP 1,925,000$68,8002.12%
Orbimed Advisors 2,124,500$75,929,6301.49%
SECTOR GAMMA AS 146,441$5,233,8011.27%
View complete list of IONIS PHARMACEUTICALS INC shareholders